Africa 
China 
Japan 
MENA 
Explore chapters and articles related to this topic
Early Pregnancy Loss
Published in Vincenzo Berghella, Obstetric Evidence Based Guidelines, 2022
Lisa K. Perriera, Beatrice A. Chen, Aileen M. Gariepy
Misoprostol is a prostaglandin E1 analogue. It is a uterotonic that results in cervical softening and contractions that expel the products of conception. Routes of administration include vaginal, oral, buccal, or sublingual. Side effects vary, based on route of administration [26].
Pregnancy, Delivery and Postpartum
Published in Miriam Orcutt, Clare Shortall, Sarah Walpole, Aula Abbara, Sylvia Garry, Rita Issa, Alimuddin Zumla, Ibrahim Abubakar, Handbook of Refugee Health, 2021
Zahra Ameen, Katy Kuhrt, Kopal Singhal Agarwal, Chawan Baran, Rebecca Best, Maria Garcia de Frutos, Miranda Geddes-Barton, Laura Bridle, Black Benjamin
The classic features are irregular vaginal bleeding, hyperemesis, excessive uterine enlargement and early failed pregnancy. A urine pregnancy test should always be carried out in women presenting with these symptoms. Ultrasound scanning in early pregnancy is useful to help make a diagnosis of molar pregnancy, but definitive diagnosis is always with histological examination of products of conception.
DRCOG MCQs for Circuit C Questions
Published in Una F. Coales, DRCOG: Practice MCQs and OSCEs: How to Pass First Time three Complete MCQ Practice Exams (180 MCQs) Three Complete OSCE Practice Papers (60 Questions) Detailed Answers and Tips, 2020
Puerperal pyrexia may be due to:Endometritis.Phlebitis.Breast abscess.Inverted uterus.Retained products of conception.
Triplet pregnancy with complete mole
Published in Journal of Obstetrics and Gynaecology, 2021
Sujata Siwatch, Minakshi Rohilla, Vanita Jain, Radhika Srinivasan, Shalini Gainder, G. R. V. Prasad
The patient had a few episodes of minor bleeding on and off. She was then noted to have an increasing pulse and an endocrine consultation was taken. Her TSH was 0.001 mIU/L and she was developing hyperthyroidism. Neomercazole 20 mg and Propranolol 40 mg were started and plan was to terminate the pregnancy in view of hyperthyroidism after arranging adequate blood products and counselling the patient. However, at this time, the patient had profuse bleeding and passed heavy clots. The products of conception were immediately evacuated with the help of ovum forceps (Figure 1(b)). Oxytocics were given and the bleeding got controlled. She was transfused one unit of blood. Repeat beta HCG after evacuation was less than 1000 IU/mL and a chest X-ray was normal. The patient was followed up with Beta HCG which fell to 5 IU/mL in four weeks. She was advised contraception and follow-up with Beta HCG.
Role of hysteroscopy in the diagnosis of uterine artery pseudoaneurysm: a case report
Published in Journal of Obstetrics and Gynaecology, 2020
Youhei Tsunoda, Takashi Matsushima, Koichi Yoneyama, Toshiyuki Takeshita
A 34-year-old woman with nulliparity was referred to our hospital after presenting with major vaginal bleeding 34 days after dilatation and curettage for a missed abortion. Colour Doppler ultrasonography revealed a mass with swirling arterial blood flow (Figure 1(A)) that was suggestive of UAP. To confirm this diagnosis, three-dimensional CT (3 D-CT) was performed. However, retained products of conception were instead suspected because of the presence of an enhanced mass in the intrauterine cavity (Figure 1(B,C)). Since it was difficult to control the patient’s bleeding and a large amount of bleeding had developed, angiography was conducted and embolisation performed. Although angiography identified the source of bleeding as a branch of the left uterine artery, UAP was not detected because its characteristic appearance of swirling arterial blood flow was not observed. We considered the possibility of retained products of conception.
The option to look: patient-centred pregnancy tissue viewing at independent abortion clinics in the United States
Published in Sexual and Reproductive Health Matters, 2020
Products of conception, also known as post-abortion pregnancy tissue,* is present in every case of pregnancy termination. This tissue is expelled during medical abortions, usually at home, or is removed by a clinician during abortions performed in a clinic or medical facility.2 Surgical abortions account for approximately 70% of the 926,200 abortions performed annually in the United States,3 resulting in almost 650,000 instances of post-abortion tissue handled by staff in the clinic setting. Seeing pregnancy tissue is a daily experience for abortion providers and staff, but it is seldom discussed outside clinic walls. Patients may ask to see their tissue after a surgical abortion, but we do not know how, when, and why these requests occur, how clinicians respond, and if or how providers facilitate patient-centred pregnancy tissue viewing (PCV).